(IN BRIEF) Novartis has appointed Mukul Mehta as CFO and Executive Committee member effective March 16, 2026. He will replace long‑time CFO Harry Kirsch, who retires on March 15, 2026, after 22 years at the company. Kirsch oversaw major strategic … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged 22-year career, Alcon spinoff, appointment, business planning and analysis, CFO appointment, digital finance, ECN, Executive Committee, focused medicines strategy, global finance leadership, GSK divestiture, Harry Kirsch, INSEAD, Jamnalal Bajaj Institute of Management Studies, leadership, March 16 2026, Mukul Mehta, Novartis, retirement, Roche divestiture, Sandoz spinoff, TAX, Vas Narasimhan
(IN BRIEF) Towards, backed by the University of Exeter, has opened its first therapy hub on a Leeds high street, offering immediate, no‑wait options for online and face‑to‑face sessions. The Leeds site kicks off a broader UK rollout staffed by … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Internet & Online, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged applied psychological practice, Catherine Gallop, Cedar Create, financial support, high‑street healthcare, in‑person therapy, Leeds therapy hub, mental health access, no waiting lists, online therapy, partnership, practical learning, Sarah Bateup, therapist training, Tim Rideout, Towards, Towards Academy, UK therapist shortage, University of Exeter
(IN BRIEF) A collaborative study by the University of Bristol, Medical Detection Dogs, and the University of Manchester found that two trained dogs can detect Parkinson’s disease from sebum skin swabs with up to 80% sensitivity and 98% specificity. In … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged biomarker, Bumper, canine detection, Claire Guest, double‑blind trial, Medical Detection Dogs, Nicola Rooney, non‑invasive diagnostics, Parkinson's disease, partnership, Pd, Peanut, Perdita Barran, sebum swabs, sensitivity 80%, specificity 98%, University of Bristol, University of Manchester
(IN BRIEF) Boehringer Ingelheim and LEO Pharma have agreed on a global license and transfer deal for SPEVIGO® (spesolimab), an antibody that blocks the IL‑36 receptor to treat generalized pustular psoriasis (GPP). LEO Pharma will assume worldwide commercialization and clinical development, harnessing … Read the full press release
Posted in Business, Denmark, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Boehringer Ingelheim, Christophe Bourdon, clinical development, commercialization, Dermatology, EUR 90 million, generalized pustular psoriasis, global license, GPP, IL‑36 receptor, LEO Pharma, monoclonal antibody, partnership, rare skin disease, Shashank Deshpande, spesolimab, SPEVIGO
(IN BRIEF) The University of Liverpool and SIMATS have signed a five-year MoU to advance collaborative health and life-science activities. This partnership encompasses joint research projects, exchange programs for undergraduates and postgraduates, co-organized academic events, and visiting-student placements, all aimed … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged academic events, Ben Pugsley, Garden City University Bengaluru, Health Sciences, joint research, life sciences, Liverpool Bengaluru campus, Living Bridge, Memorandum of Understanding, MoU, partnership, Saveetha Institute of Medical and Technical Sciences, Shakila Thangaratinam, SIMATS, strategic partnership, student exchange, UK-India collaboration, University of Liverpool, visiting students
(IN BRIEF) Fresenius Kabi’s Santiago de Besteiros plant in Portugal has secured BSI Kitemark™ Certification for Minimized Risk of AMR in its Ceftriaxone production, confirming compliance with the AMR Industry Alliance’s Antibiotic Manufacturing Standard. Key measures include stringent controls to … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Portugal, Science, Technology
Tagged AMR, AMR Industry Alliance, antibiotic efficacy, Antibiotic Manufacturing Standard, antimicrobial resistance, BSI Kitemark Certification, Ceftriaxone, Cristina Fernandes, EHS Management, emissions control, environmental protection, Fresenius Kabi, partnership, PORTUGAL, responsible pharmaceutical production, Santiago de Besteiros, sustainability, wastewater management, Zyad Hatquai
IN BRIEF) TUM will launch the Center for Structural and Functional Connectomics (CSFC) on its Garching campus—a €69 million initiative approved by the GWK—to comprehensively map neural networks and accelerate research into multiple sclerosis, neuro-oncology, and developmental neurological disorders. Spanning … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged AI-supported imaging, Center for Structural and Functional Connectomics, computational modeling, connectomics, CSFC, developmental neurological disorders, DZNE, DZPG, electron microscopy, Garching campus, GWK funding, Helmholtz Munich, light microscopy, Max Planck Society, microscopy, multiple sclerosis, Munich Institute of Biomedical Engineering, neuro-oncology, neuronal connections, Prof. Franz Pfeiffer, Prof. Julijana Gjorgjieva, Prof. Thomas Misgeld, SyNergy Cluster of Excellence, TUM, X-ray microscopy, €69 million
(IN BRIEF) The University of Liverpool has launched the Liverpool Interdisciplinary Neuroscience Centre (LINC), an ambitious collaboration uniting nearly 170 researchers and clinicians from the University, The Walton Centre NHS Foundation Trust, Brain Health Northwest, and global partners. LINC aims … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged Alder Hey Children’s NHS Foundation Trust, brain health, Brain Health Northwest, brain tumours, British Neuroscience Association, chronic pain, David Fairclough, diagnostics, Dr Andy Nicolson, epilepsy, Epilepsy Research Institute, interdisciplinary research, LINC, Liverpool Interdisciplinary Neuroscience Centre, mental health, Mersey Care, neurodegeneration, neurological disorders, neurosurgery, Professor Benedict Michael, Professor Louise Kenny, Psychiatry, Roche Diagnostics UK & Ireland, The Walton Centre NHS Foundation Trust, therapies, University of Liverpool, WHO Global Action Plan
(IN BRIEF) EIB Global is lending €143.5 million to Termoelectrica SA for a seven-year overhaul of Chisinau’s district heating network—horizontalizing pipelines, installing individual substations, and upgrading 1 665 apartment buildings—to cut energy use by 25% and emissions by 7%. A … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Infrastructure & Utilities, Investment, Luxembourg, Moldova
Tagged Ala Nemerenco, Cahul hospital, Chişinău, CO₂ reduction, district heating, Dorin Junghietu, E5P, EBRD, EIB Global, energy efficiency, EPTATF, EU for Ukraine Advisory Programme, EU grants, EU integration, European Investment Bank, horizontal pipelines, individual substations, Jānis Mažeiks, Ministry of Health, MOLDOVA, Swedfund, Teresa Czerwinska, Termoelectrica SA
(IN BRIEF) Empa has introduced a novel 4D X-ray diagnostic that combines synchronized biplanar X-ray videos with CT-derived 3D bone models to quantify shoulder joint motion with 0.1–0.5 mm precision. This approach uncovers instabilities invisible to static imaging or skin-marker … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Switzerland, Technology
Tagged 4D X-ray analysis, Ameet Aiyangar, Biomechanics, biplanar radiography, clinical innovation, CT, CT 3D models, dynamic diagnosis, Empa, Inselspital Bern, joint instability, motion capture, MRI, musculoskeletal modeling, radiation-free diagnostics, Schulterinstabilität, shoulder kinematics, sitem-insel, sub-millimeter precision
(IN BRIEF) The EIB has extended a €150 million loan to Alfasigma to fund its R&D efforts from 2025 to 2027, targeting new drugs in gastroenterology, hepatology, vascular medicine, rheumatology, and rare diseases. The financing, endorsed by EIB Vice-President Gelsomina … Read the full press release
Posted in Banks, Business, Economy, Financial, Government, Healthcare, Industrial, Investment, Italy, Luxembourg, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Alfasigma, biopharmaceutical innovation, EIB, European competitiveness, European Investment Bank, gastroenterology, Gelsomina Vigliotti, hepatology, job creation, partnership, patient-centred therapies, R&D financing, rare diseases, rheumatology, specialty care, Tatiana Simonelli, Vascular Medicine
(IN BRIEF) University of Bristol researchers and partners have created the first international Core Information Set (CIS) for innovative surgical procedures, published in the British Journal of Surgery. Arising from the 2018 “First Do No Harm” review, the CIS comprises … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged Angus McNair, British Journal of Surgery, clinical governance, Core Information Set, First Do No Harm review, informed consent, innovative surgery, NIHR Bristol Biomedical Research Centre, partnership, patient empowerment, patient safety, pelvic mesh, regulatory standards, shared decision-making, surgical ethics, University of Bristol
(IN BRIEF) Basilea Pharmaceutica has secured an extra USD 39 million from BARDA under its Other Transaction Agreement, bringing potential non-dilutive funding to USD 268 million over 12 years. This new tranche will finance the ongoing phase 3 trial of … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Allschwil, antibacterial, antifungal, ASPR, BAL2062, BARDA, Basilea Pharmaceutica Ltd, Cresemba®, fosmanogepix, HHS, invasive candidiasis, invasive mold infections, multidrug-resistant Candida auris, orphan drug, Other Transaction Agreement, partnership, QIDP, Switzerland, Zevtera®
(IN BRIEF) Boehringer Ingelheim has initiated the THULITE Phase II trial (NCT06962839) to assess BI 1815368, a novel oral agent for diabetic macular edema (DME). Affecting more than 21 million people globally, DME is typically managed by frequent eye injections, … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged at-home treatment, BI 1815368, BI 764524, biopharmaceutical research, Boehringer Ingelheim, Charles C. Wykoff, clinical trial NCT06962839, CRIMSON trial, Dario Madani, diabetic macular edema, diabetic retinal disease, DME, intravitreal injections, macular edema, oral therapy, Patrick Bussfeld, PRO RETINA, retinal vascular hyperpermeability, Sema3A antibody, THULITE Phase II, vision loss
A European collaboration developing predictive tools to personalise aortic surgery, enhance prosthesis selection, and support clinical decision-making (IN BRIEF) PANDORA is an EU-funded collaboration uniting LivGemini, RBF Morph, INSA and UnivREN—alongside Rennes University Hospital—to create patient-specific “digital twins” of the … Read the full press release
Posted in Artificial Intelligence (AI), European Union, France, Healthcare, Italy, Pharma & Biotech, Science, Technology
Tagged 3D models, AIinCardiology, Ansys, Aortic Aneurysms, aortic surgery, AorticAneurysm, AorticSurgery, artificial intelligence, B2B2B approach, biomedical engineer, cardiovascular numerical simulation, Cardiovascular Surgery, CardiovascularHealth, CardiovascularSimulation, Dacron prostheses, datasets, DigitalHealth, DigitalTwin, epidemiological studies, EU-funded, FFplus consortium, H2020 project, HorizonEurope, HPCinHealthcare, In-Silico Modelling, INSA, InSilicoMedicine, InSilicoSurgery, Institut National des Sciences Appliquées, Leonardo Geronzi PhD, LivGemini, LTSI laboratory, Medical Device Manufacturers, medical image analysis, MedicalImageAnalysis, MeDiTATe, MedTechInnovation, mesh morphing algorithms, NumericalSimulation, PANDORA, Pandora Project, PANDORAproject, para-anastomotic aneurysms, post-implant prosthesis kinking, post-surgery coronary perfusion, predictive assessment of aortic surgery outcomes, predictive tools, PredictiveSurgery, prosthesis, RBF Morph, SurgicalPlanning, Université de Rennes, University Hospital of Rennes, UnivREN
(IN BRIEF) EQT Healthcare Growth will acquire a controlling interest in Europa Biosite from Adelis Equity. Europa Biosite, based in Stockholm, distributes over ten million life science research products—antibodies, biochemicals, diagnostic kits, and biospecimens—to more than 60,000 researchers across 17 … Read the full press release
Posted in Business, Chemicals, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Sweden, Technology
Tagged Adelis Equity, antibodies, Azelis, Beijer Ref, biochemicals, biospecimens, commercial excellence, diagnostic kits, digital infrastructure, EQT Healthcare Growth, Europa Biosite, healthcare distribution, Kate Swann, life science reagents, M&A, OEM International, partnership, research tools, Research Use Only, Rikke Kjær Nielsen, Stockholm, Sune Schmølker
(IN BRIEF) The European Commission has approved AstraZeneca’s Imfinzi (durvalumab) combined with gemcitabine and cisplatin as neoadjuvant therapy, followed by Imfinzi adjuvant monotherapy, for adults with resectable muscle-invasive bladder cancer. This approval is anchored in NIAGARA Phase III trial data … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged adjuvant monotherapy, AstraZeneca, cisplatin, curative intent, Dave Fredrickson, durvalumab, ESMO, European Commission, event-free survival, gemcitabine, Imfinzi, immunotherapy, MIBC, Michiel Van der Heijden, muscle-invasive bladder cancer, neoadjuvant chemotherapy, New England Journal of Medicine, NIAGARA Phase III, NMIBC, overall survival, radical cystectomy
(IN BRIEF) EIB Global, funded by a €50,000 Cities Climate Finance Gap Fund grant and in collaboration with GIZ, will advise Kenyatta National Hospital on installing a solar PV system. The technical studies and financial assessment will guide the integration … Read the full press release
Posted in Banks, Business, Economy, Energy, Gas & Oil, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, Marketing, News, Technology
Tagged carbon footprint reduction, Cities Climate Finance Gap Fund, climate-smart infrastructure, diesel generators, Dr. Evanson Kamuri, Edward Claessen, EIB Global, Energy Independence, financial assessment, GIZ, Kenyatta National Hospital, Nairobi, partnership, photovoltaic system, solar power, Sustainable Healthcare, technical studies
(IN BRIEF) The University of Southampton and University Hospital Southampton NHS Foundation Trust will open the £100 million Institute for Medical Innovation at Southampton General Hospital. This new building will co-locate researchers in medicine, engineering, and computer science to tackle … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged biomedical engineering, cancer research, Centre for Cancer Immunology, David French, dementia research, fundraising campaign, IMI, infectious diseases, Institute for Medical Innovation, interdisciplinary collaboration, medical computing, medical training, partnership, Professor Mark E. Smith, respiratory conditions, Sight Loss, Southampton General Hospital, Southampton medical hub, state-of-the-art labs, translational research, University Hospital Southampton NHS Foundation Trust, University of Southampton
Sober.Buzz along with @SoberBuzzToken on Instagram are Impacting and Changing Lives Around the World with Real, Raw, Authentic Content is now a Member of the NXC Podcast Network Family which Further Expands Its Ability for “Spreading the Good BUZZ” (IN … Read the full press release
Posted in Apparel, Fashion & Beauty, Entertainment, Healthcare, Internet & Online, Media, News, Retail, Society
Tagged addiction, AddictionRecovery, addicts, alcohol addiction, Alcoholics, APA, Bitcoin, Cassie Uptmore, celebrities, crypto, cryptocurrency, drug addiction, GlobalCommunity, Gregory Kirkham, Heidi Case, inspirational messages, InspirationalContent, Josh Case, JoshAndHeidi, JudgmentFree, mental health, mental health professionals, MentalHealth, nline store, NXC Podcast Network, NXCNetwork, podcast, PodcastLaunch, RawAndReal, recovery, RecoveryCommunity, RecoveryJourney, SGNO, Sober, Sober.Buzz, SoberBuzz, SoberBuzzToken, SoberCurious, Sobriety, sobriety platform, SobrietyMerch, Society of Gynecologic Nurse Oncologists, SpreadingTheGoodBUZZ, SupportAndHope, the American Psychiatric Association, the Washington Psychiatric Society, TheBuzzByCassie, token sale, TokenSale, trauma, WPS, “Spreading the Good BUZZ”
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?